All National Institute for Health and Care Excellence (NICE) articles – Page 22
-
NewsHospitals criticised over baby infection delays
Some hospitals are causing “unnecessary delays” in treating newborn babies suffering from infections, the healthcare watchdog has said.
-
CommentUniting voices in epilepsy treatment
Patients and clinicians can lead in standard and availability of neurosurgical options
-
NewsNicholson orders trusts to offer approved drugs
All NHS organisations have been ordered to publish details of which drugs they will routinely fund in a bid to make sure patients get medicines they are legally entitled to.
-
NewsNICE proposes indicators for holding CCGs to account
The National Institute for Health and Clinical Excellence has suggested 44 indicators which could be used to monitor the success of clinical commissioning groups.
-
HSJ KnowledgePatients 'should take trusts to court' over drug access
‘Numerous trusts are acting unlawfully… denying patients an innovative and cost-effective treatment,’ writes NICE chair Sir Michael Rawlins in a recent HSJ article. Read the article, listen to the BBC’s follow-up and share your views.
-
CommentMichael Rawlins: playing fair on treatments
A few weeks ago, Steve Winyard, head of policy and campaigns at the Royal National Institute of Blind People (RNIB), asked to see me.
-
HSJ KnowledgeHow GPs can remove obstacles to QIPP targets
Delivering the QIPP targets is proving a tough challenge for GP practices. Paul Cook offers some practical ideas on how to remove the obstacles in the way.
-
NewsNICE: trusts must offer DVT tests within 24 hours
Hospitals have been set “challenging” new clinical targets to provide a “seven-days-a-week” service for patients presenting with a suspected venous thromboembolism.
-
CommentCommissioning outcomes framework will enable meaningful quality improvement
The framework will help organisations prioritise performance issues.
-
NewsLansley confirms NICE will no longer take funding decisions
The National Institute for Health and Clinical Excellence will no longer directly decide whether the NHS funds a drug under the proposed new pricing system, health secretary Andrew Lansley has confirmed.
-
NewsDrug costs 'have to be secret' under new pricing system
Drug prices agreed under the government’s proposed new pricing system would have to remain secret if drug companies are to buy into it, a senior figure in the pharmaceutical industry has warned.
-
News
Mike Rawlins: NICE drug judgements can be improved
Judgements on which drugs should be paid for by the NHS can be improved, the chair of the National Institute for Health and Clinical Excellence has said.
-
CommentMichael White: driving down the cost of drug deals
The NHS should have little sympathy for Big Pharma.
-
HSJ Local
TIA clinic leads the way for Nottingham
STRUCTURE: Nottingham University Hospitals NHS Trust has become one the first hospitals in the country to set up a dedicated nurse-led clinic to care for patients who have had a minor stroke or transient ischaemic attack (TIA).
-
NewsValue-based pricing 'will not improve' cancer drug access
Government proposals to introduce a value-based pricing system for new drugs will not significantly improve patient access to treatments, experts have warned.
-
News
NICE guidance on cost-saving drug not sought by DH
The Department of Health failed to act on expert advice to commission an appraisal of a drug which could lead to savings of £100m for the NHS, it has emerged.
-
HSJ KnowledgeGuidance on producing an any qualified provider implementation pack
The chance to produce an AQP implementation pack offered potent insights into how the service area should develop. Sheena Hennell explains how one PCT cluster went about their project.
-
NewsPM declares 'national crisis' over dementia care
The prime minister has declared that rising rates of dementia are “a national crisis” and launched a major drive to improve the lives of sufferers and their carers.
-
LeaderHSJ…more for healthcare leaders
One thing unites HSJ readers, whether they have a clinical or non-clinical background, work in the NHS or provide services from the private sector: they are all leaders.
-
Comment'The NHS needs to be better at adopting innovation'
Sir Michael Rawlins on the importance of innovating.